retatrutide ly3437943 triple agonist gip glp-1 glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide 30mg | 20-Vial Kit
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1























![Mewtwo LV.X (144/146) (Stallgon - David Cohen) [World Championships 2009] 40](https://cdn.shopify.com/s/files/1/0644/7818/3517/files/9f723030-dc4b-5f14-b9c0-1c494ee8a814.jpg?v=1746040675)




